Mission Creek Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,094
| Closed | -$212K | – | 224 |
|
|
2024
Q2 | $212K | Sell |
5,094
-10,909
| -68% | -$453K | 0.05% | 200 |
|
|
2024
Q1 | $868K | Sell |
16,003
-10,558
| -40% | -$573K | 0.23% | 118 |
|
|
2023
Q4 | $1.36M | Buy |
26,561
+1,270
| +5% | +$65.2K | 0.35% | 84 |
|
|
2023
Q3 | $1.47M | Buy |
25,291
+1,130
| +5% | +$65.6K | 0.49% | 63 |
|
|
2023
Q2 | $1.55M | Buy |
24,161
+3,326
| +16% | +$213K | 0.5% | 63 |
|
|
2023
Q1 | $1.44M | Buy |
20,835
+4,359
| +26% | +$302K | 0.49% | 74 |
|
|
2022
Q4 | $1.19M | Buy |
16,476
+110
| +0.7% | +$7.91K | 0.42% | 83 |
|
|
2022
Q3 | $1.16M | Buy |
16,366
+938
| +6% | +$66.7K | 0.44% | 81 |
|
|
2022
Q2 | $1.19M | Buy |
15,428
+251
| +2% | +$19.3K | 0.4% | 90 |
|
|
2022
Q1 | $1.11M | Buy |
15,177
+833
| +6% | +$60.8K | 0.3% | 108 |
|
|
2021
Q4 | $894K | Buy |
14,344
+474
| +3% | +$29.5K | 0.18% | 140 |
|
|
2021
Q3 | $821K | Buy |
13,870
+1,103
| +9% | +$65.3K | 0.15% | 140 |
|
|
2021
Q2 | $853K | Buy |
12,767
+3,941
| +45% | +$263K | 0.14% | 125 |
|
|
2021
Q1 | $557K | Buy |
8,826
+622
| +8% | +$39.3K | 0.08% | 149 |
|
|
2020
Q4 | $509K | Buy |
8,204
+2,878
| +54% | +$179K | 0.16% | 143 |
|
|
2020
Q3 | $321K | Buy |
5,326
+660
| +14% | +$39.8K | 0.13% | 169 |
|
|
2020
Q2 | $274K | Sell |
4,666
-344
| -7% | -$20.2K | 0.14% | 143 |
|
|
2020
Q1 | $279K | Sell |
5,010
-46
| -0.9% | -$2.56K | 0.15% | 134 |
|
|
2019
Q4 | $325K | Buy |
+5,056
| New | +$325K | 0.15% | 148 |
|